Industry analysis indicates the Aquaculture Vaccines Market globally will expand at a 7.5% CAGR during 2024–2034.
Aquaculture Vaccines covers reshaping how healthcare entities approach this space.
Market momentum is supported by mounting call for advanced solutions, favorable regulatory frameworks, and robust investment in research and development across major economies.
Segmental analysis reveals differentiated growth across product categories, applications, and geographical regions, with certain niches demonstrating above-average expansion potential.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and mounting investment in the sector.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Aquaculture Vaccines Market Snapshot
Chapter 4. Global Aquaculture Vaccines Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter's Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ MN), 2024-2034
4.8. Global Aquaculture Vaccines Market Penetration & Growth Prospect Mapping (US$ Mn),
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10. Use/impact of AI on Aquaculture Vaccines Market Industry Trends
Chapter 5. Aquaculture Vaccines Market Segmentation 1: By Vaccine Type, Estimates & Trend Analysis
5.1. Market Share by Vaccine Type, 2023 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Vaccine Type:
5.2.1. Inactivated Vaccine
5.2.2. Attenuated Live Vaccine
5.2.3. Others
Chapter 6. Aquaculture Vaccines Market Segmentation 2: By Application, Estimates & Trend Analysis
6.1. Market Share by Application, 2023 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Application:
6.2.1. Bacterial Infection
6.2.2. Viral Infections,
6.2.3. Others - Combined Bacterial and Viral Infections, parasitic
Chapter 7. Aquaculture Vaccines Market Segmentation 3: By Route of Administration, Estimates & Trend Analysis
7.1. Market Share by Route of Administration, 2023 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Route of Administration:
7.2.1. Immersion Vaccines
7.2.2. Injection Vaccines
7.2.3. Oral Vaccines
Chapter 8. Aquaculture Vaccines Market Segmentation 4: By Species, Estimates & Trend Analysis
8.1. Market Share by Species, 2023 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Species:
8.2.1. Cold Water
8.2.1.1. Salmon
8.2.1.2. Trout
8.2.1.3. Turbot
8.2.1.4. Others
8.2.2. Hot Water
8.2.2.1. Tilapia
8.2.2.2. Seabass and Seabream
8.2.2.3. Others
Chapter 9. Aquaculture Vaccines Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Aquaculture Vaccines Market, Regional Snapshot 2023 & 2034
9.2. North America
9.2.1. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.2.1.1. US
9.2.1.2. Canada
9.2.2. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.2.3. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.2.4. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.2.5. North America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.3. Europe
9.3.1. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.3.1.1. Norway
9.3.1.2. Greece
9.3.1.3. Spain
9.3.1.4. Russia
9.3.1.5. UK
9.3.1.6. Rest of Europe
9.3.2. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.3.3. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.3.4. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.3.5. Europe Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.4. Asia Pacific
9.4.1. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.4.1.1. China
9.4.1.2. Indonesia
9.4.1.3. Vietnam
9.4.1.4. india
9.4.1.5. Bangladesh
9.4.1.6. Phillipines
9.4.1.7. Rest of Asia Pacific
9.4.2. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.4.3. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.4.4. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts By Route of Administration, 2024-2034
9.4.5. Asia Pacific Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.5. Latin America
9.5.1. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Country, 2024-2034
9.5.1.1. Chile
9.5.1.2. Brazil
9.5.1.3. Mexico
9.5.1.4. Ecuador
9.5.1.5. Rest of Latin America
9.5.2. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.5.3. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.5.4. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.5.5. Latin America Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
9.6. Middle East & Africa
9.6.1. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2034
9.6.1.1. Egypt
9.6.1.2. Turkey
9.6.1.3. Iran
9.6.1.4. GCC countries
9.6.1.5. Rest of Middle East and Africa
9.6.2. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Vaccine Type, 2024-2034
9.6.3. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Application, 2024-2034
9.6.4. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Route of Administration, 2024-2034
9.6.5. Middle East & Africa Aquaculture Vaccines Market Revenue (US$ Million) Estimates and Forecasts by Species, 2024-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Pharmaq AS (Zoetis, LLC)
10.2.1.1. Business Overview
10.2.1.2. Key Product/Service
10.2.1.3. Financial Performance
10.2.1.4. Geographical Presence
10.2.1.5. Recent Developments with Business Strategy
10.2.2. Merck Animal Health (Merck & Co., Inc.)
10.2.3. KoVax Ltd. (Part of Phibro Animal Health)
10.2.4. Hipra
10.2.5. Tecnovax SA
10.2.6. Veterquimica S.A.
10.2.7. Nisseiken Co. Ltd.
10.2.8. Virbac S.A.
10.2.9. Elanco
10.2.10. Kyoritsuseiyaku Corporation
10.2.11. Vaxxinova International BV
10.2.12. KBNP
10.2.13. Kemin Industries, Inc.
10.2.14. Kyoto Biken Laboratories, Inc.
10.2.15. CAVAC
10.2.16. Other Prominent Players